Intraluminal Pulsed Dose Rate (PDR) brachytherapy and trans-hepatic technique in treatment of locally advanced bile duct cancer - preliminary assessment. Rep Pract Radioth Oncol 2007; 2: 125-133.SKOWRONEK J, SOWIER A, SKRZYWANEK P. Intralu- minal pulsed dose rate (PDR) brachytherapy and trans...
The US Food and Drug Administration (FDA) has granted accelerated approval of a newtargeted therapyfor use in some patients withcholangiocarcinoma, a rare cancer of the bile ducts. The product ispemigatinib(Pemazyre, Incyte), an oral kinase inhibitor. It was approved specifically for use in pat...
The ministry expects the approval of Pemazyre to provide a new treatment option for adult patients with locally progressive or metastatic bile duct cancer who have received one more systemic treatment and have the experience of FGFR2 fusion or rearrangement. “The government will continue to do its...
“Unfortunately, bile duct cancer today has a poor prognosis for patients,” commented Dr. Novelli in the RenovoRx’s press release. “Despite early diagnosis, the 5-year survival rate is approximately 24%. There are currently limited treatment options for patients diagnosed with this aggressive...
ductstoneperoralcholangioscopyEUSTakeshi2Ogura2Kazuhide2Higuchi2InformaworldExpert Review of Gastroenterology & HepatologyOgura T,Higuchi K.A review of treatment options for bile duct stones[J].Expert Rev Gastroenterol Hepatol,2016,10(11):1271-1278....
Infigratinib was approved for use in adults with previously treated unresectable bile duct cancer harboring an FGFR2 fusion or other rearrangement.
Due to late diagnosis and lack of palliative care and adequate treatment methods, the prognosis of bile duct tumors is mostly poor (Pahernik et al., 1998). Understanding the mechanisms that lead to cellular resistance may be more effective in developing new treatments for bile duct cancer (BDC...
Norton Cancer Institute, the leading provider of cancer care in Louisville and Southern Indiana, offers same-day appointments for patients newly diagnosed with cholangiocarcinoma, also known as bile duct cancer. Bile ducts carry bile and waste from inside the liver to the gallbladder and small intes...
9 Rarely, the bile duct may develop a stricture following irradiation for cancer therapy. Bile duct stones can cause strictures, a unique variety of which is seen in Mirizzi syndrome. Intrahepatic stones can embed (epithelialize) into the bile duct wall, giving the appearance of a malignant or...
Treatment of Metastatic Disease The majority of studies evaluating systemic therapies have included patients with both gallbladder and bile duct cancers, which were discussed at length in the gallbladder section (see “Gallbladder Cancer” above). We anticipate that as a more sophisticated understanding...